Evan J. Luxenberg , Monica Solorio , Kathleen Munger , Andrew Ayars , Yujie Wang
{"title":"免疫缺陷者的神经系统自身免疫:一例常见变异性免疫缺陷患者的神经脊髓炎视网膜病变","authors":"Evan J. Luxenberg , Monica Solorio , Kathleen Munger , Andrew Ayars , Yujie Wang","doi":"10.1016/j.nerep.2024.100208","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Neuromyelitis optica (NMO) is a relapsing CNS autoimmune disorder most commonly characterized by longitudinally extensive transverse myelitis (LETM) and/or optic neuritis (ON). Common variable immunodeficiency (CVID) is the most common clinically significant primary immunodeficiency, characterized by immune dysregulation and decreased immunoglobulin production. Autoimmunity is common in CVID, however neurologic autoimmunity is exceedingly rare and co-occurrence with NMO has not been previously described. We present the case of a man in his 60′s with CVID who developed LETM and was subsequently diagnosed with Aquaporin (AQP) 4 Immunoglobulin G (IgG) seropositive NMO.</p></div><div><h3>Methods</h3><p>Chart review of a patient treated at the University of Washington.</p></div><div><h3>Results</h3><p>Our patient had been treated with intravenous immunoglobulin therapy for CVID for 5 years when he presented with subacute onset of ascending paraparesis, sensory loss, and urinary retention. MRI identified LETM from C3 to T9. AQP4 IgG was markedly elevated at a titer of >1:100,000. He responded well to immunotherapy.</p></div><div><h3>Conclusion</h3><p>Autoimmunity in CVID is thought to be from loss of regulatory T cell function as well as increased peripheral plasmablasts. We highlight the importance of considering autoimmune CNS diseases in primary immunodeficiencies as well as review possible pathophysiology of neurologic autoimmunity in CVID.</p></div>","PeriodicalId":100950,"journal":{"name":"Neuroimmunology Reports","volume":"5 ","pages":"Article 100208"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667257X24000093/pdfft?md5=fe80dd97279820ef37010933feaee642&pid=1-s2.0-S2667257X24000093-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Neurologic autoimmunity in the immunodeficient: A case of neuromyelitis optica in an individual with common variable immunodeficiency\",\"authors\":\"Evan J. Luxenberg , Monica Solorio , Kathleen Munger , Andrew Ayars , Yujie Wang\",\"doi\":\"10.1016/j.nerep.2024.100208\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>Neuromyelitis optica (NMO) is a relapsing CNS autoimmune disorder most commonly characterized by longitudinally extensive transverse myelitis (LETM) and/or optic neuritis (ON). Common variable immunodeficiency (CVID) is the most common clinically significant primary immunodeficiency, characterized by immune dysregulation and decreased immunoglobulin production. Autoimmunity is common in CVID, however neurologic autoimmunity is exceedingly rare and co-occurrence with NMO has not been previously described. We present the case of a man in his 60′s with CVID who developed LETM and was subsequently diagnosed with Aquaporin (AQP) 4 Immunoglobulin G (IgG) seropositive NMO.</p></div><div><h3>Methods</h3><p>Chart review of a patient treated at the University of Washington.</p></div><div><h3>Results</h3><p>Our patient had been treated with intravenous immunoglobulin therapy for CVID for 5 years when he presented with subacute onset of ascending paraparesis, sensory loss, and urinary retention. MRI identified LETM from C3 to T9. AQP4 IgG was markedly elevated at a titer of >1:100,000. He responded well to immunotherapy.</p></div><div><h3>Conclusion</h3><p>Autoimmunity in CVID is thought to be from loss of regulatory T cell function as well as increased peripheral plasmablasts. We highlight the importance of considering autoimmune CNS diseases in primary immunodeficiencies as well as review possible pathophysiology of neurologic autoimmunity in CVID.</p></div>\",\"PeriodicalId\":100950,\"journal\":{\"name\":\"Neuroimmunology Reports\",\"volume\":\"5 \",\"pages\":\"Article 100208\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2667257X24000093/pdfft?md5=fe80dd97279820ef37010933feaee642&pid=1-s2.0-S2667257X24000093-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neuroimmunology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2667257X24000093\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neuroimmunology Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2667257X24000093","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Neurologic autoimmunity in the immunodeficient: A case of neuromyelitis optica in an individual with common variable immunodeficiency
Background
Neuromyelitis optica (NMO) is a relapsing CNS autoimmune disorder most commonly characterized by longitudinally extensive transverse myelitis (LETM) and/or optic neuritis (ON). Common variable immunodeficiency (CVID) is the most common clinically significant primary immunodeficiency, characterized by immune dysregulation and decreased immunoglobulin production. Autoimmunity is common in CVID, however neurologic autoimmunity is exceedingly rare and co-occurrence with NMO has not been previously described. We present the case of a man in his 60′s with CVID who developed LETM and was subsequently diagnosed with Aquaporin (AQP) 4 Immunoglobulin G (IgG) seropositive NMO.
Methods
Chart review of a patient treated at the University of Washington.
Results
Our patient had been treated with intravenous immunoglobulin therapy for CVID for 5 years when he presented with subacute onset of ascending paraparesis, sensory loss, and urinary retention. MRI identified LETM from C3 to T9. AQP4 IgG was markedly elevated at a titer of >1:100,000. He responded well to immunotherapy.
Conclusion
Autoimmunity in CVID is thought to be from loss of regulatory T cell function as well as increased peripheral plasmablasts. We highlight the importance of considering autoimmune CNS diseases in primary immunodeficiencies as well as review possible pathophysiology of neurologic autoimmunity in CVID.